Cargando…
Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West
BACKGROUND AND AIMS: The Barcelona Clinic Liver Cancer (BCLC) stage C (BCLC C) of hepatocellular carcinoma (HCC) includes a heterogeneous population for which sorafeninb is one of the recommended therapies. We aim to evaluate the real world clinical treatment and survival of BCLC stage C patients in...
Autores principales: | Yen, Yi-Hao, Cheng, Yu-Fan, Wang, Jing-Houng, Lin, Chih-Che, Chen, Yen-Yang, Yong, Chee-Chien, Liu, Yueh-Wei, Cheng, Jen-Yu, Chen, Chien-Hung, Hu, Tsung-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067409/ https://www.ncbi.nlm.nih.gov/pubmed/32163475 http://dx.doi.org/10.1371/journal.pone.0230005 |
Ejemplares similares
-
Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West
por: Yen, Yi-Hao, et al.
Publicado: (2021) -
Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias
por: Yen, Yi-Hao, et al.
Publicado: (2021) -
Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center
por: Liu, Yueh-Wei, et al.
Publicado: (2020) -
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021) -
Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)